Cargando…

Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats

Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chung-Ping, Huang, Ching-Ya, Lin, Shiuan-Pey, Hou, Yu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326880/
https://www.ncbi.nlm.nih.gov/pubmed/29703381
http://dx.doi.org/10.1016/j.jfda.2017.11.005
_version_ 1784757388346130432
author Yu, Chung-Ping
Huang, Ching-Ya
Lin, Shiuan-Pey
Hou, Yu-Chi
author_facet Yu, Chung-Ping
Huang, Ching-Ya
Lin, Shiuan-Pey
Hou, Yu-Chi
author_sort Yu, Chung-Ping
collection PubMed
description Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-glycoprotein (P-gp) and CYP3A4 in order to investigate the in vivo modulation effect of CR on P-gp and CYP3A4. Three groups of rats were orally administered CSP without and with single dose or repeated dosing of CR in a parallel design. Blood samples were collected at specific time points and the blood CSP concentration was determined by a specific monoclonal fluorescence polarization immunoassay. The results showed that a single dose (1.0 g/kg) and the 7th dose (1.0 g/kg) of CR significantly decreased the C(max) of CSP by 56.9% and 70.4%, and reduced the AUC(0-540) by 56.4% and 68.7%, respectively. Cell study indicated that CR decoction, berberine, coptisine, palmatine all activated the efflux transport of P-gp. Ex-vivo study showed that the serum metabolites of CR activated CYP 3A4. In conclusion, through using CSP as an in vivo probe substrate, we have verified that oral intake of CR activated the functions of P-gp and CYP3A based on in vivo and in vitro studies.
format Online
Article
Text
id pubmed-9326880
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93268802022-08-09 Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats Yu, Chung-Ping Huang, Ching-Ya Lin, Shiuan-Pey Hou, Yu-Chi J Food Drug Anal Original Article Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-glycoprotein (P-gp) and CYP3A4 in order to investigate the in vivo modulation effect of CR on P-gp and CYP3A4. Three groups of rats were orally administered CSP without and with single dose or repeated dosing of CR in a parallel design. Blood samples were collected at specific time points and the blood CSP concentration was determined by a specific monoclonal fluorescence polarization immunoassay. The results showed that a single dose (1.0 g/kg) and the 7th dose (1.0 g/kg) of CR significantly decreased the C(max) of CSP by 56.9% and 70.4%, and reduced the AUC(0-540) by 56.4% and 68.7%, respectively. Cell study indicated that CR decoction, berberine, coptisine, palmatine all activated the efflux transport of P-gp. Ex-vivo study showed that the serum metabolites of CR activated CYP 3A4. In conclusion, through using CSP as an in vivo probe substrate, we have verified that oral intake of CR activated the functions of P-gp and CYP3A based on in vivo and in vitro studies. Taiwan Food and Drug Administration 2017-12-14 /pmc/articles/PMC9326880/ /pubmed/29703381 http://dx.doi.org/10.1016/j.jfda.2017.11.005 Text en © 2018 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Yu, Chung-Ping
Huang, Ching-Ya
Lin, Shiuan-Pey
Hou, Yu-Chi
Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title_full Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title_fullStr Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title_full_unstemmed Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title_short Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
title_sort activation of p-glycoprotein and cyp 3a by coptidis rhizoma in vivo: using cyclosporine as a probe substrate in rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326880/
https://www.ncbi.nlm.nih.gov/pubmed/29703381
http://dx.doi.org/10.1016/j.jfda.2017.11.005
work_keys_str_mv AT yuchungping activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats
AT huangchingya activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats
AT linshiuanpey activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats
AT houyuchi activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats